Signals mentioning CDSCO
- India weighs red warning labels on cough syrups for young children
- Dr. Reddy’s to bring Takeda’s QDENGA dengue vaccine to India’s private market in H1 2027
- Karnataka FDA seizes ₹4.02 lakh in medicines from Amazon-linked Bengaluru facilities
- CBIC standardises import-clearance checklists for cosmetics, drugs and medical devices
- India eyes 40–45% local value addition in next medical-device PLI
- India mandates tighter drug quality norms, raising compliance pressure across pharma supply
- India prioritises GMP enforcement and biopharma push to protect pharmacy-of-the-world status
- CDSCO tightens sampling rules: 10 monthly samples per inspector, rural surveillance push
- CDSCO bars injectable cosmetics, jolts India's $1.6B medical aesthetics market
- CDSCO Bars Injectables From 'Cosmetic' Labelling, Targets GLP-1 Off-Label Use
- DCGI tells aesthetic clinics, beauty brands: cosmetics are for beautifying, not treatment
- CDSCO bars cosmetic injectables, squeezing India's aesthetic clinic chains
- CDSCO orders contingency plan as 20,000 chemists strike May 20 over e-pharmacy threat
- Chemist strike on 20 May loses steam as 12 state bodies withdraw after CDSCO assurance
- AIOCD May 20 bandh fizzles as 12 state pharmacy bodies opt out after CDSCO review pledge
- DCGI orders nationwide crackdown on illegal sildenafil, tadalafil sales across pharmacies and e-platforms